Pertussis toxin is one of the major virulence determinants produced by Bordetella pertussis. The DNA encoding the structural genes for pertussis toxin was cloned in Escherichia coli, and pertussis toxin subunit S4 was expressed under the control of the tac promoter. Mutations were introduced into the cloned toxin genes, and a conjugative shuttle vector system was devised for delivering the mutations from E. coli back into B. pertussis. The mutations were introduced by allelic exchange into the chromosome of B. pertussis resulting in a series of B. pertussis strains which were isogenic except at the loci encoding the structural genes for pertussis toxin. These B. pertussis strains were utilized to study the biogenesis of pertussis toxin. Polar mutations in the S1 gene led to a lack of detectable S2 or S4 subunits in whole-cell lysates, suggesting a polycistronic arrangement for these genes. Mutations in the SS subunit gene resulted in a truncated S1 subunit, while mutations in the S4 gene resulted in a lack of detectable S2 subunit, suggesting that physical relationships among the toxin subunits are directly reflected in the stable biogenesis of the subunits.
Pertussis toxin, produced by Bordetella pertussis, is a protein exotoxin which is central to the pathogenesis of whooping cough. Whooping cough is multiphasic. During an initial catarrhal phase, B. pertussis colonizes the host nasopharynx and damages local tissue. The subsequent paroxysmal phase reflects a systemic intoxication of the host by pertussis toxin. Some aspects of the disease associated with the paroxysmal phase, such as lymphocytosis, hypoglycemia, and reactogenicity, can be duplicated in animal models by administration of pertussis toxin alone (18, 22) . The toxin alters host physiology by covalently attaching an ADPribose moiety to certain guanine nucleotide-binding proteins involved in transduction of hormonal signals across eucaryotic membranes (2, 11) .
The structure of pertussis toxin conforms to the A-B model for bacterial toxins (25) . An "A" peptide monomer, designated S1, is the ADP-ribosyltransferase (10) . A "B" component oligomer, composed of four different peptides designated S2, S3, S4, and S5, mediates binding to host tissue (26) . The five subunits, S1 through S5, are present in a 1:1:1:2:1 ratio.
The region of the B. pertussis chromosome which encodes pertussis toxin was originally identified by a transposon insertion that inhibited phenotypic expression of the toxin (28) . Specifically, this insertion was shown to inactivate expression of toxin subunit S3 (16) . We have named the chromosomal region surrounding the transposon insertion ptx (28) . This chromosomal region has been cloned and sequenced, and the sequence data suggest a polycistronic, operonlike structure with open reading frames for all five pertussis toxin subunits arranged contiguously (14, 19) . The finding that the transposon insertion was in the open reading frame assigned to subunit S3 supported the sequence-based assignments of the toxin genes (19) .
In an earlier report, we described the genetic modification of the B. pertussis chromosome by transposon mutagenesis (28) . We have now extended this technique of genetic modification and report here the allelic exchange of defined mutations into the ptx region of the B. pertussis chromosome. These mutations enabled us to initiate an investigation of the pertussis toxin operon and its control.
MATERIALS & METHODS
Strains and media. The bacterial strains used in this study are listed in Table 1 . Escherichia coli was cultured on L agar (15) , and B. pertussis was grown on Bordet Gengou agar (28) with 15% sheep blood at 37°C. B. pertussis was incubated in jars loosely stoppered to maintain high humidity. Antibiotics were included, when appropriate, at the following concentrations: ampicillin, 100 ,ug/ml for E. coli and 40 p.g/ml for B. pertussis; kanamycin, 40 ,ug/ml; rifampin, 50 ju.g/ml; streptomycin, 400 p,g/ml.
Nucleic acid manipulations. General cloning techniques were used in recombinant DNA molecule constructions (15) . Large preparations of plasmid DNA for recombinant constructions and small preparations for rapid screening of plasmid constructions were prepared by alkaline lysis (15 (Fig. 1) . pTOX9 was constructed from plasmids p11.11 ( Fig. 1) (27) , and IncP rlx provided a means for conjugative mobilization of pTOX9 from E. coli into B. pertussis (27) . The cloned B. pertussis DNA, the ColEl oriV, and the ampicillin resistance gene were provided by the 10.0-and 3.6-kilobase-pair (kb) BglII fragments from p11.11. IncP rlx was provided by a 0.7-kb fragment from pEYDG1. The three fragments were combined such that the integrity of the ptx locus was maintained and the only remaining BglII site in pTOX9 was in the pertussis toxin operon.
Plasmid pKANTr was constructed for production of a polylinker-flanked aminoglycoside-phosphotransferase-3'-I (APH) gene (a kanamycin resistance marker [20] ) and was an insertion of the polylinker-flanked APH gene into the EcoRI site of pBR322 (15) . A derivative of the ptacl2 expression vector (15) , pRI133 (provided by R. R. Isberg), was utilized for cloning random DNA fragments from cosmid p11.11. pRI133 contains the APH gene (20) inserted into the EcoRI site of ptacl2 but is otherwise identical to ptacl2. The fragments of p11.11 were generated by sonication by the method of Deininger (5) and were cloned into the PvuII site of pRI133 immediately adjacent to the tac promoter.
The mutations generated in the cloned B. pertussis DNA of pTOX9 were each marked with an inserted kanamycin resistance (APH) gene and were constructed such that the B. pertussis DNA flanking the mutation would facilitate recombination into the B. pertussis chromosome. The mutations were either deletions, with the kanamycin resistance gene ligated into the breach, or insertions of the kanamycin resistance gene at specific sites within the operon. Deletion mutations were created by digestion of pTOX9 with restriction endonuclease BglII, followed by digestion with Bal 31 exonuclease (15) . Bal 31 exonuclease-digested plasmids were treated with Klenow polymerase (15) to form blunt ends. The kanamycin resistance gene generated as a HincII fragment from pKANnr was then ligated to the deleted pTOX9 to permit recircularization. For the single-point insertions, pTOX9 was partially digested with restriction endonuclease Sau3A in the presence of ethidium bromide as described by Parker et al. (21) . This yielded a population of circularly permuted, linear pTOX9 molecules, each cut at only one Sau3A site. The kanamycin resistance gene generated as a BamHI-cut fragment from pKANmr was then ligated to the linear pTOX9 molecules to permit recircularization.
Genetics. Mutations created in the pTOX9 shuttle vector were introduced into the B. pertussis BP370 chromosome by allelic exchange (24) . The shuttle vector derivatives were conjugatively mobilized into B. pertussis in triparental matings utilizing the helper plasmid pRKTV5 (28) . E. coli HB101 (18 h old) and B. pertussis BP370 (60 h old) plate cultures were swabbed together onto Bordet Gengou agar plates containing 10 .0 mM MgCl2. Mating mixtures were incubated at 37°C for 3.5 h in loosely stoppered jars followed by reswabbing onto Bordet Gengou agar medium supplemented with 40 ,ug of kanamycin per ml and 50 pug of rifampin per ml.
The rifampin was used to counterselect donor E. coli. Since pTOX9 was unable to replicate autonomously in B. pertussis, plating on kanamycin-containing medium selected those exconjugants in which the plasmid had recombined into the B. pertussis chromosome. By subsequently scoring for loss of the ampicillin resistance encoded by the plasmid vector sequence, while maintaining selection for kanamycin resistance, we identified exconjugants which had gained the kanamycin resistance-marked mutated ptx allele and concomitantly lost the wild-type ptx allele and plasmid vector sequence.
Immunological assays. B. pertussis toxin mutants were analyzed by Western immunoblotting (4) . To detect all subunits present, we assayed whole-cell lysates of the mutants. B. pertussis strains were grown on Bordet Gengou agar and were prepared for analysis by suspension in water followed by heating in solubilization buffer (12) at 100°C for 5 min. Preparations were electrophoresed in 15% polyacrylamide gels by the method of Laemmli (12) , transferred to nitrocellulose by the method of Burnette (4), and probed with antibody and labeling reagents in BLOTTO buffer (9) . Gel samples of whole-cell lysates were difficult to equilibrate, and thus autoradiographic signals were only used qualitatively. Purified pertussis toxin for use as a standard was purchased from List Biological Laboratories. Rabbit antiserum to pertussis toxin was provided by E. L. Hewlett. (14, 19) , is indicated by, and proceeds from, the 5' to the 3' designations. Plasmids pTOX1, pTOX9, and p11.11, described in the text, contain cloned ptx DNA. B. pertussis-derived DNA is denoted by a thin line; vector DNA is denoted by a thick line. The vector sequence of p11.11 has been truncated to facilitate inclusion in the diagram. The position and direction of the tac promoter (tacP) in pTOX1 is indicated. The site of the transposon insertion which defined the ptx region, ptxCl::TnS (28) Pertussis toxin expressed from the tac promoter in E. coli was labeled with [35S]methionine (Amersham) in vitro (3), using reagents prepared from E. coli HB101. Labeled peptide products of the in vitro transcription-translation reactions were isolated by radioimmunoprecipitation (8) utilizing monoclonal antibody A2B5/G9 (provided by J. J. Munoz), specific for pertussis toxin subunit S4, and rabbit anti-mouse immunoglobulin Immunobeads (Bio-Rad Laboratories, Richmond, Calif.). Labeled peptides were electrophoresed in 15% polyacrylamide gels (12) and autoradiographed (15) .
RESULTS
The ptx region of the B. pertussis chromosome has been shown by transposon mutagenesis (28) and DNA sequence analysis (14, 19) to encode the genes for the pertussis toxin peptide subunits. The sequence data indicate that the genes are arranged contiguously and suggest a polycistronic, operonlike structure. Two putative promoters have been identified from the sequence data, one preceding the S1 subunit gene (14, 19) and a second preceding the S4 subunit gene (13) . To study the regulation of the toxin genes, we cloned this chromosomal region in the cosmid p11.11 ( Fig. 1) (A. A. Weiss and S. Falkow, unpublished data). The subunit genes have previously been referred to by the peptide designations, S1 through S5 (14, 19) . In this report, we assigned the genetic loci associated with these genes as ptxA (S1), ptxB (S2), ptxC (S3), ptxD (S4), and ptxE (S5). Also, consistent with the transcriptional direction for the genes predicted by the DNA sequence (14, 19) , we call the ptxA end of the operon, 5', and the ptxC end, 3' (Fig. 1) .
Expression of pertussis toxin subunit S4 in E. coli. We were unable to detect expression of pertussis toxin in E. coli from the cloned sequence in cosmid p11.11. Therefore, we cloned randomly generated fragments of the ptx region into an E. coli tac promoter expression vector, pRI133, to determine whether translation of pertussis toxin was possible in E. coli. E. coli HB101 was transformed with the plasmid clones, and one, designated pTOX1, was found to be associated with production of pertussis toxin antigenic material as assayed with an antisera by colony blot radioimmunoassay (data not shown). Restriction mapping of the B. pertussis DNA cloned in pTOX1 indicated that it included all the genes for subunits S2, S4, S5, and S3, but only a portion of the gene for subunit S1 (Fig. 1) . Furthermore, the toxin operon DNA was fused to the tac promoter with the appropriate transcriptional orientation predicted by the DNA sequence. Peptides produced by pTOX1 and the vector pRI133 were labeled with [35S]methionine in vitro in transcription-translation reactions and subsequently precipitated with a monoclonal antibody specific for pertussis toxin subunit S4. Polyacrylamide gel electrophoresis indicated that a peptide encoded by pTOX1 migrated with the apparent molecular weight for toxin subunit S4, ca. 12,000 (Fig. 2) . Other [35S]methionine-labeled peptides which were encoded by pTOX1 but not by pRI133 (Fig. 2A, 1) , the vector pRI133 (lanes 2), or pTOX1 (lanes 3). Labeled products were then either directly electrophoresed in a sodium dodecyl sulfate-polyacrylamide gel (A) or precipitated with monoclonal antibody A2B5/G9, specific for pertussis toxin subunit S4, and then electrophoresed (B) . Apparent molecular size is indicated in kilodaltons (kD).
express a pertussis toxin subunit from the tac promoter in E. coli, our primary interest was to examine the regulation of pertussis toxin expression from its own promoter. To do so, we utilized allelic exchange to introduce defined mutations into the B. pertussis chromosomal ptx loci. The ptx mutations were constructed in the shuttle vector pTOX9 (Fig. 1) by insertion of a kanamycin resistance gene into various sites in the ptx DNA. The constructions were designed such that the B. pertussis DNA flanking each mutational insertion facilitated recombination into the B. pertussis chromosome. The mutations were of two general forms: deletions marked with an inserted kanamycin resistance gene, and point insertions of the kanamycin resistance gene (Fig. 1) . The kanamycin resistance gene cassette contained its own promoter and so was not dependent on the transcriptional control of the pertussis toxin operon. A ClaI site in the kanamycin resistance gene, located asymmetrically with respect to the ends of the cassette, allowed us to determine the transcriptional direction of the gene insertions (Fig. 1) .
We confirmed that the mutations were introduced at the chromosomal ptx loci of the exconjugants by Southern transfer analysis. Chromosomal DNA from B. pertussis ptx mutants was digested with ClaI and probed with the 1.2-kb kanamycin gene cassette and the 4.7-kb EcoRI fragment from the ptx region. The bands to which the kanamycin gene cassette hybridized were identical in size to the bands detected with the ptx probe (Fig. 3) . This indicated that the kanamycin resistance gene, and the mutations, were introduced at the ptx loci.
We were thus able to generate a series of B. pertussis strains which were isogenic except at their ptx loci. In addition to genetically defining the ptx loci, these mutations provided a means by which the genetic regulation of the operon could be studied. The insertions of the kanamycin resistance gene, whether at a Sau3A site or into a deletion, interrupted the transcriptional control of the operon at the point of insertion. It was thus possible to determine how interruption of the operon with any given point insertion or deletion affected biogenesis of the toxin.
Pertussis toxin biogenesis. The pertussis toxin operon sequence data suggested the presence of two promoterlike regions, one preceding the Si gene and a second preceding the S4 gene (13, 14, 19) . If only the promoter preceding the Si gene was active, all five subunit genes would form a single transcriptional unit, and any interruption of the operon proximal to this promoter would be polar for all genes in the operon. Alternatively, if the second promoter, preceding the S4 gene, was also active, then S4 biogenesis could conceivably occur independently of Si and S2 biogenesis. Therefore, we were interested in determining the effect of the mutation ptxA571 on the biogenesis of subunit S4. ptxA5171 is an insertion of the kanamycin resistance gene into the Si gene, proximal to the first putative promoter (Fig. 1) . B. pertussis TOX5171, which contains the ptxA5171 allele, was scored by immunoblot for the presence of toxin subunits. We could not detect Si, S2, or S4 subunits in lysates of TOX5171 (Fig. 4, lane d) , although they were clearly evident in the parental strain BP370 containing the wild-type operon (Fig. 4, lane b) . Furthermore, insertions of the kanamycin resistance gene outside of the toxin operon, such as in strains TOX5105 (ptx-5105) and TOX5167 (ptx-5167), had no effect on S1, S2, or S4 biogenesis (Fig. 4, lanes c and g) . It appeared that biogenesis of toxin subunit S4 was dependent on the integrity of the operon proximal to the first promoter. This is consistent with the notion that only the first promoterlike sequence was active in controlling S4 expression.
It should be noted that lysates of wild-type strains contained two peptides which bound the anti-Si monoclonal antibody. One peptide comigrated with the Si peptide of purified pertussis toxin at an apparent molecular weight of ca. 27,000 (Fig. 4, lane a) . The other peptide, at a lower apparent molecular weight of ca. 20,000, was not found in purified pertussis toxin preparations. Neither of the Si peptides was present in lysates of the operon deletion mutant TOX3311 [A(ptxA-ptxC)3311] or of the Si gene insertion mutant TOX5171 (Fig. 4) (Fig. 1) . The mutations of these strains were well distal to the Si gene and also, of course, to the proposed promoter for the Si gene. Yet strains harboring these mutations contained only the truncated form of subunit S1 (Fig. 4, lanes h and j) . In contrast, the B. pertussis strain with the ptx-5148 allele, an interruption of the operon downstream (or 3') of the S5 gene ( Fig. 1) , produced wild-type Si (Fig. 4, lane f) (Fig. 1 ). Yet strains harboring these mutations contained no discernable S2 subunit (Fig. 4, lanes  e and i) . In contrast, the B. pertussis strain with the AptxE3305 allele, an interruption of the operon downstream (or 3') of the S4 gene (Fig. 1) , produced wild-type S2 (Fig. 4,  lane h ). These data are consistent with the view that interruption of the S4 subunit gene adversely affected the synthesis or stability of subunit S2.
DISCUSSION
Pertussis toxin is one of the major virulence determinants produced by B. pertussis. The genetic locus encoding pertussis toxin has been identified (28) , and the genes have been cloned and sequenced (14, 19) . Previous reports (14, 19) and our own work indicated that pertussis toxin was not expressed from toxin genes cloned in E. coli. We have now been able to express pertussis toxin subunit S4 in E. coli under control of an E. coli promoter. Expression of the toxin under the control of an exogenous promoter is consistent with a recent report of Barbieri et al. (1) who expressed Si as a fusion peptide under control of the lac promoter. More importantly, we were able to examine toxin gene expression by creating defined mutations in the chromosomal pertussis toxin genes. These mutations enabled us to establish several points regarding pertussis toxin biogenesis.
The first is that biogenesis of toxin subunits S2 and S4 requires an intact and uninterrupted Si gene. This may indicate that the first three genes of the operon form a single transcriptional unit, that is, they are polycistronic. Two putative promoters have been identified in the pertussis toxin operon DNA sequence (13, 14, 19 
